Millennium Management’s Phathom Pharmaceuticals PHAT Stock Holding History

Millennium Management’s Portfolio PHAT Stock Details PHAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$36.6M	Sell	3,375,834 -647,075	-16%	-$7.38M	0.01%	1110
2026 Q1	$44.7M	Buy	4,022,909 +1,940,729	+93%	+$24.5M	0.02%	904
2025 Q4	$34.5M	Sell	2,082,180 -2,999,271	-59%	-$42.8M	0.01%	1070
2025 Q3	$59.8M	Buy	5,081,451 +2,830,954	+126%	+$29.2M	0.03%	743
2025 Q2	$21.6M	Buy	2,250,497 +1,727,134	+330%	+$9.56M	0.01%	1504
2025 Q1	$3.28M	Buy	523,363 +463,372	+772%	+$2.81M	﹤0.01%	3296
2024 Q4	$487K	Buy	59,991 +27,063	+82%	+$335K	﹤0.01%	4772
2024 Q3	$595K	Buy	+32,928	New	+$460K	﹤0.01%	4692
2024 Q2	–	Sell	-225,024	Closed	-$2.39M	–	6374
2024 Q1	$2.39M	Buy	225,024 +54,980	+32%	+$467K	﹤0.01%	3572
2023 Q4	$1.55M	Buy	170,044 +30,696	+22%	+$264K	﹤0.01%	3809
2023 Q3	$1.45M	Buy	139,348 +111,407	+399%	+$1.53M	﹤0.01%	3881
2023 Q2	$400K	Sell	27,941 -29,922	-52%	-$345K	﹤0.01%	4697
2023 Q1	$413K	Buy	+57,863	New	+$508K	﹤0.01%	4718
2022 Q4	–	Sell	-50,396	Closed	-$558K	–	6928
2022 Q3	$558K	Buy	+50,396	New	+$480K	﹤0.01%	4872
2021 Q2	–	Sell	-12,090	Closed	-$454K	–	6963
2021 Q1	$454K	Sell	12,090 -61,287	-84%	-$2.56M	﹤0.01%	4898
2020 Q4	$2.44M	Buy	+73,377	New	+$2.97M	﹤0.01%	3086

Other funds holding PHAT

FLSM

Frazier Life Sciences Management Palo Alto, California $4.59B AUM 237.58% 1-Year Est. Return

MVM

Medicxi Ventures Management St. Helier, Jersey $177M AUM 212.06% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Carlyle Group Washington, District of Columbia $10B AUM 10.61% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

GKIM

GW&K Investment Management Boston, Massachusetts $12.8B AUM 48.82% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

NMC

NEA Management Company Timonium, Maryland $1.59B AUM 234.06% 1-Year Est. Return

6CM

683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return

Millennium Management's PHAT Position: Q2 2026 in Review

Millennium Management reduced its Phathom Pharmaceuticals (PHAT) stake by 16% in Q2 2026, selling an estimated $7.38M and leaving 3,375,834 shares worth $36.6M. The position accounts for 0.01% of the portfolio, ranked #1110.

Millennium Management first reported a position in PHAT in Q4 2020 and has held it in 16 quarters since. The position peaked at $59.8M in Q3 2025. 162 funds tracked by Wall St. Rank hold PHAT as of Q2 2026.

Millennium Management held 3,375,834 shares of Phathom Pharmaceuticals worth $36.6M as of Q2 2026.
Millennium Management sold 647,075 Phathom Pharmaceuticals shares in Q2 2026, an estimated $7.38M.
Phathom Pharmaceuticals made up 0.01% of Millennium Management's portfolio in Q2 2026, its #1110 holding.
Millennium Management first reported a position in Phathom Pharmaceuticals in Q4 2020 and has held it in 16 quarters since.
Millennium Management's Phathom Pharmaceuticals position peaked at $59.8M in Q3 2025.
162 funds tracked by Wall St. Rank held Phathom Pharmaceuticals as of Q2 2026.

Based on Millennium Management's 13F filing for Q2 2026, filed 14 Aug 2026.